Tevogen Bio Holdings Statistics
Total Valuation
TVGN has a market cap or net worth of $1.07 billion. The enterprise value is $1.03 billion.
Important Dates
The next estimated earnings date is Thursday, April 2, 2026, before market open.
| Earnings Date | Apr 2, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
TVGN has 202.42 million shares outstanding. The number of shares has increased by 32.33% in one year.
| Current Share Class | 4.05M |
| Shares Outstanding | 202.42M |
| Shares Change (YoY) | +32.33% |
| Shares Change (QoQ) | +6.36% |
| Owned by Insiders (%) | 85.60% |
| Owned by Institutions (%) | 2.52% |
| Float | 582,919 |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.31
| Current Ratio | 0.31 |
| Quick Ratio | 0.18 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -219.50 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -439.67% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | 1,376.93% |
| Weighted Average Cost of Capital (WACC) | 0.15% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.75M |
| Employee Count | 18 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -90.80% in the last 52 weeks. The beta is -0.75, so TVGN's price volatility has been lower than the market average.
| Beta (5Y) | -0.75 |
| 52-Week Price Change | -90.80% |
| 50-Day Moving Average | 13.10 |
| 200-Day Moving Average | 33.52 |
| Relative Strength Index (RSI) | 21.04 |
| Average Volume (20 Days) | 43,320 |
Short Selling Information
The latest short interest is 2.92 million, so 1.44% of the outstanding shares have been sold short.
| Short Interest | 2.92M |
| Short Previous Month | 3.00M |
| Short % of Shares Out | 1.44% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 4.08 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -30.89M |
| Pretax Income | -31.04M |
| Net Income | -31.42M |
| EBITDA | -30.72M |
| EBIT | -30.89M |
| Earnings Per Share (EPS) | -$9.41 |
Full Income StatementBalance Sheet
The company has $1.04 million in cash and $7.53 million in debt, with a net cash position of -$6.49 million or -$0.03 per share.
| Cash & Cash Equivalents | 1.04M |
| Total Debt | 7.53M |
| Net Cash | -6.49M |
| Net Cash Per Share | -$0.03 |
| Equity (Book Value) | -7.82M |
| Book Value Per Share | -4.21 |
| Working Capital | -4.62M |
Full Balance SheetCash Flow
| Operating Cash Flow | -13.19M |
| Capital Expenditures | n/a |
| Free Cash Flow | -13.19M |
| FCF Per Share | -$0.07 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
